Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM

Item

http://www.wikidata.org/entity/Q36697855

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Discriminant ratio and biometr ...... ein B100 in patients with T2DM

@ast

Discriminant ratio and biometr ...... ein B100 in patients with T2DM

@en

type

Item

label

Discriminant ratio and biometr ...... ein B100 in patients with T2DM

@ast

Discriminant ratio and biometr ...... ein B100 in patients with T2DM

@en

prefLabel

Discriminant ratio and biometr ...... ein B100 in patients with T2DM

@ast

Discriminant ratio and biometr ...... ein B100 in patients with T2DM

@en

P1476

Discriminant ratio and biometr ...... ein B100 in patients with T2DM

@en

P2093

Michel F Rousseau

http://www.w3.org/2001/XMLSchema#string

Michel P Hermans

http://www.w3.org/2001/XMLSchema#string

Sylvie A Ahn

http://www.w3.org/2001/XMLSchema#string

P2860

Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes

Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes

Evaluation of methods for the measurement of low-density lipoprotein cholesterol.

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.

Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.

Estimation of plasma apolipoprotein B concentration using routinely measured lipid biochemical tests in apparently healthy Asian adults

P2888

1475-2840-12-39

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-12-39

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235749744

http://www.w3.org/2001/XMLSchema#string

P6179

1012829208

http://www.w3.org/2001/XMLSchema#string

P698

23446247

http://www.w3.org/2001/XMLSchema#string

P932

3601994

http://www.w3.org/2001/XMLSchema#string